Ophthalmic Disease Treatment Product Developer

Recombinant Protein Drug Developer

Clinical Genetic Diagnosis, Prevention, and Gene Therapy Drug Development for Hereditary Eye Diseases

ExpectedReadReading Time: 2 Minutes







As an important carrier of Beijing's international science and technology innovation center, the "Three Cities and One Area" main platform, Zhongguancun Life Science Park has gathered numerous innovative companies in cutting-edge fields such as precision medicine, biopharmaceuticals, high-end medical devices, and gene technology. The five selected companies are all representative innovative forces within the park.
Genetron Health has mature technical accumulation in the field of precision oncology, providing end-to-end solutions from testing to treatment.(Click here to view more); Super Vision Technology, Inc. focuses on the research and development of high-end ophthalmic medical devices and medical chips, and its selected projectImplantable Visual Cortex Spatiotemporal Interference Neural Stimulator Project, adopting innovative spatiotemporal interference electric field technology, breaks through the limitations of traditional visual restoration technologies and constructs a new mapping system based on "animal EEG recording – relay transmission – stimulation parameter execution."(Click here to view more); QL Biopharm is committed to the development of innovative biologics, and its oral GLP-1 class drug has been approved to enter the clinical trial stage.(Click here to view more); TopAllBio focuses on the research and development of new drugs for autoimmune diseases,With a global patent layout(Click here to view more); CHIGENOVO Co., Ltd. focuses on the field of ophthalmic gene therapy, and its in vivo gene editing drug has entered the clinical stage.(Click here to view more)。
In the future, with the policy dividends and resource advantages of special support, these enterprises will further accelerate the tackling of core technologies, expand production capacity, and promote the market landing of products. At the same time, they will also inject new momentum into the Zhongguancun Life Science Park to strengthen the industrial cluster effect and enhance regional innovation competitiveness.
